Related Experiment Video

Updated: Jul 9, 2026

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

L-arginine metabolism and its impact on host immunity against Leishmania infection

Nanchaya Wanasen1, Lynn Soong

  • 1Department of Microbiology, Institute for Human Infections and Immunity, Center for Biodefense and Emerging Infections, Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555-1070, USA.

Immunologic Research
|November 28, 2007
PubMed

Insights

L-arginine metabolism critically impacts Leishmania infection outcomes. Understanding its role in host immune responses and parasite replication is key for developing new therapies against this vector-borne disease.

Area of Science:

  • Immunology
  • Parasitology
  • Molecular Biology

Background:

  • Leishmaniasis is a global vector-borne disease caused by Leishmania parasites.
  • Parasites infect mammalian macrophages, making their activation status crucial for infection outcome.
  • L-arginine is vital for both parasite killing (via nitric oxide) and replication (via polyamines).

Purpose of the Study:

  • To review the role of L-arginine in Leishmania infection.
  • To explore L-arginine's influence on host immune responses in vitro and in vivo.
  • To discuss therapeutic strategies targeting L-arginine metabolism.

Main Methods:

  • Literature review of studies on Leishmania infection and L-arginine metabolism.
  • Analysis of in vitro and in vivo experimental data.
  • Synthesis of information on therapeutic approaches.

Main Results:

  • L-arginine availability dictates Leishmania parasite fate within macrophages.
  • Nitric oxide production, dependent on L-arginine, is essential for parasite clearance.
  • Polyamines, also derived from L-arginine, support parasite replication.

Conclusions:

  • L-arginine is a central metabolic factor influencing Leishmania infection dynamics.
  • Targeting L-arginine pathways offers potential therapeutic avenues for leishmaniasis.
  • Further research into L-arginine metabolism is crucial for effective disease control.

More Related Videos

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites10:01

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites

Published on: March 16, 2018

Related Concept Videos

Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...